DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. Often, these slides are referred to as gene chips or DNA chips.
Âé¶¹Ô´´ Analysis and Insights: Global DNA and Gene Chips Âé¶¹Ô´´
The global DNA and Gene Chips market is projected to grow from US$ 6593.9 million in 2024 to US$ 10910 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
Report Covers:
This report presents an overview of global market for DNA and Gene Chips market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of DNA and Gene Chips, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for DNA and Gene Chips, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA and Gene Chips revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global DNA and Gene Chips market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for DNA and Gene Chips revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
Bio MérieuxSA
Thermo Fisher Scientific Inc.
Savyon Diagnostics
Agilent Technologies
Applied Micro Arrays Illumina Inc.
Toshiba Hokuto Electronics Corporation
TOSHIBA Perkin Elmer Inc.
Oxford Gene Technology
Arrayit Corporation
MYcroarray Macrogen Inc.
Greiner Bio One
Asper Biotech
CapitalBio Corporation
Microarrays Inc.
Segment by Type
Cancer Diagnosis and Treatment
Gene Expression
Genotyping
Genomics
Drug Discovery
Agricultural Biotechnology
Others
Segment by Application
Academic and Government Research Institutes
Hospitals and Diagnostics Centers
Biotechnology and Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of DNA and Gene Chips in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA and Gene Chips companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA and Gene Chips revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global DNA and Gene Chips Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cancer Diagnosis and Treatment
1.2.3 Gene Expression
1.2.4 Genotyping
1.2.5 Genomics
1.2.6 Drug Discovery
1.2.7 Agricultural Biotechnology
1.2.8 Others
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global DNA and Gene Chips Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Academic and Government Research Institutes
1.3.3 Hospitals and Diagnostics Centers
1.3.4 Biotechnology and Pharmaceutical Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA and Gene Chips Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global DNA and Gene Chips Growth Trends by Region
2.2.1 DNA and Gene Chips Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 DNA and Gene Chips Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 DNA and Gene Chips Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 DNA and Gene Chips Âé¶¹Ô´´ Dynamics
2.3.1 DNA and Gene Chips Industry Trends
2.3.2 DNA and Gene Chips Âé¶¹Ô´´ Drivers
2.3.3 DNA and Gene Chips Âé¶¹Ô´´ Challenges
2.3.4 DNA and Gene Chips Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue DNA and Gene Chips by Players
3.1.1 Global DNA and Gene Chips Revenue by Players (2019-2024)
3.1.2 Global DNA and Gene Chips Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global DNA and Gene Chips Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of DNA and Gene Chips, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global DNA and Gene Chips Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global DNA and Gene Chips Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA and Gene Chips Revenue in 2023
3.5 Global Key Players of DNA and Gene Chips Head office and Area Served
3.6 Global Key Players of DNA and Gene Chips, Product and Application
3.7 Global Key Players of DNA and Gene Chips, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA and Gene Chips Breakdown Data by Type
4.1 Global DNA and Gene Chips Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global DNA and Gene Chips Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 DNA and Gene Chips Breakdown Data by Application
5.1 Global DNA and Gene Chips Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global DNA and Gene Chips Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America DNA and Gene Chips Âé¶¹Ô´´ Size (2019-2030)
6.2 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Type
6.2.1 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America DNA and Gene Chips Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Application
6.3.1 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America DNA and Gene Chips Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Country
6.4.1 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe DNA and Gene Chips Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Type
7.2.1 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe DNA and Gene Chips Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Application
7.3.1 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe DNA and Gene Chips Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Country
7.4.1 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China DNA and Gene Chips Âé¶¹Ô´´ Size (2019-2030)
8.2 China DNA and Gene Chips Âé¶¹Ô´´ Size by Type
8.2.1 China DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China DNA and Gene Chips Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China DNA and Gene Chips Âé¶¹Ô´´ Size by Application
8.3.1 China DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China DNA and Gene Chips Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia DNA and Gene Chips Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Type
9.2.1 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia DNA and Gene Chips Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Application
9.3.1 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia DNA and Gene Chips Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Region
9.4.1 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia DNA and Gene Chips Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America DNA and Gene Chips Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bio MérieuxSA
11.1.1 Bio MérieuxSA Company Details
11.1.2 Bio MérieuxSA Business Overview
11.1.3 Bio MérieuxSA DNA and Gene Chips Introduction
11.1.4 Bio MérieuxSA Revenue in DNA and Gene Chips Business (2019-2024)
11.1.5 Bio MérieuxSA Recent Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. DNA and Gene Chips Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in DNA and Gene Chips Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc. Recent Developments
11.3 Savyon Diagnostics
11.3.1 Savyon Diagnostics Company Details
11.3.2 Savyon Diagnostics Business Overview
11.3.3 Savyon Diagnostics DNA and Gene Chips Introduction
11.3.4 Savyon Diagnostics Revenue in DNA and Gene Chips Business (2019-2024)
11.3.5 Savyon Diagnostics Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies DNA and Gene Chips Introduction
11.4.4 Agilent Technologies Revenue in DNA and Gene Chips Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 Applied Micro Arrays Illumina Inc.
11.5.1 Applied Micro Arrays Illumina Inc. Company Details
11.5.2 Applied Micro Arrays Illumina Inc. Business Overview
11.5.3 Applied Micro Arrays Illumina Inc. DNA and Gene Chips Introduction
11.5.4 Applied Micro Arrays Illumina Inc. Revenue in DNA and Gene Chips Business (2019-2024)
11.5.5 Applied Micro Arrays Illumina Inc. Recent Developments
11.6 Toshiba Hokuto Electronics Corporation
11.6.1 Toshiba Hokuto Electronics Corporation Company Details
11.6.2 Toshiba Hokuto Electronics Corporation Business Overview
11.6.3 Toshiba Hokuto Electronics Corporation DNA and Gene Chips Introduction
11.6.4 Toshiba Hokuto Electronics Corporation Revenue in DNA and Gene Chips Business (2019-2024)
11.6.5 Toshiba Hokuto Electronics Corporation Recent Developments
11.7 TOSHIBA Perkin Elmer Inc.
11.7.1 TOSHIBA Perkin Elmer Inc. Company Details
11.7.2 TOSHIBA Perkin Elmer Inc. Business Overview
11.7.3 TOSHIBA Perkin Elmer Inc. DNA and Gene Chips Introduction
11.7.4 TOSHIBA Perkin Elmer Inc. Revenue in DNA and Gene Chips Business (2019-2024)
11.7.5 TOSHIBA Perkin Elmer Inc. Recent Developments
11.8 Oxford Gene Technology
11.8.1 Oxford Gene Technology Company Details
11.8.2 Oxford Gene Technology Business Overview
11.8.3 Oxford Gene Technology DNA and Gene Chips Introduction
11.8.4 Oxford Gene Technology Revenue in DNA and Gene Chips Business (2019-2024)
11.8.5 Oxford Gene Technology Recent Developments
11.9 Arrayit Corporation
11.9.1 Arrayit Corporation Company Details
11.9.2 Arrayit Corporation Business Overview
11.9.3 Arrayit Corporation DNA and Gene Chips Introduction
11.9.4 Arrayit Corporation Revenue in DNA and Gene Chips Business (2019-2024)
11.9.5 Arrayit Corporation Recent Developments
11.10 MYcroarray Macrogen Inc.
11.10.1 MYcroarray Macrogen Inc. Company Details
11.10.2 MYcroarray Macrogen Inc. Business Overview
11.10.3 MYcroarray Macrogen Inc. DNA and Gene Chips Introduction
11.10.4 MYcroarray Macrogen Inc. Revenue in DNA and Gene Chips Business (2019-2024)
11.10.5 MYcroarray Macrogen Inc. Recent Developments
11.11 Greiner Bio One
11.11.1 Greiner Bio One Company Details
11.11.2 Greiner Bio One Business Overview
11.11.3 Greiner Bio One DNA and Gene Chips Introduction
11.11.4 Greiner Bio One Revenue in DNA and Gene Chips Business (2019-2024)
11.11.5 Greiner Bio One Recent Developments
11.12 Asper Biotech
11.12.1 Asper Biotech Company Details
11.12.2 Asper Biotech Business Overview
11.12.3 Asper Biotech DNA and Gene Chips Introduction
11.12.4 Asper Biotech Revenue in DNA and Gene Chips Business (2019-2024)
11.12.5 Asper Biotech Recent Developments
11.13 CapitalBio Corporation
11.13.1 CapitalBio Corporation Company Details
11.13.2 CapitalBio Corporation Business Overview
11.13.3 CapitalBio Corporation DNA and Gene Chips Introduction
11.13.4 CapitalBio Corporation Revenue in DNA and Gene Chips Business (2019-2024)
11.13.5 CapitalBio Corporation Recent Developments
11.14 Microarrays Inc.
11.14.1 Microarrays Inc. Company Details
11.14.2 Microarrays Inc. Business Overview
11.14.3 Microarrays Inc. DNA and Gene Chips Introduction
11.14.4 Microarrays Inc. Revenue in DNA and Gene Chips Business (2019-2024)
11.14.5 Microarrays Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio MérieuxSA
Thermo Fisher Scientific Inc.
Savyon Diagnostics
Agilent Technologies
Applied Micro Arrays Illumina Inc.
Toshiba Hokuto Electronics Corporation
TOSHIBA Perkin Elmer Inc.
Oxford Gene Technology
Arrayit Corporation
MYcroarray Macrogen Inc.
Greiner Bio One
Asper Biotech
CapitalBio Corporation
Microarrays Inc.
Ìý
Ìý
*If Applicable.